论文部分内容阅读
目的分析布地奈德联合肺力咳治疗小儿哮喘的临床疗效及应用价值。方法选取2013年4月—2015年3月期间收治的90例小儿哮喘患儿,随机分为观察组与常规组,各45例。常规组采用布地奈德进行治疗,观察组在吸入布地奈德气雾剂的基础上口服肺力咳。统计两组患儿治疗时间、止咳时间;比较两组患儿临床治疗效果以及患儿家属满意度。结果观察组治疗时间与止咳时间明显低于常规组,差异显著(P<0.05);观察组患儿91.11%治疗效果与86.67%的家属满意度,明显高于常规组77.78%的治疗效果与73.33%的满意度,差异显著(P<0.05)。结论布地奈德联合肺力咳治疗小儿哮喘能够有效进行止咳,改善肺功能指标,缩短治疗时间,提高患儿治疗效果与家属满意度,有利于维护医患关系,具有良好的临床推广应用价值。
Objective To analyze the clinical efficacy and clinical value of Budesonide combined with Pulmonary cough in the treatment of pediatric asthma. Methods Ninety children with asthma admitted from April 2013 to March 2015 were randomly divided into observation group and conventional group, with 45 cases in each group. The conventional group was treated with budesonide. The observation group was given oral cough on the basis of inhaled budesonide aerosol. Statistics two groups of children treatment time, cough time; compared the clinical efficacy of two groups of children and their families satisfaction. Results The treatment time and cough time in the observation group were significantly lower than those in the conventional group (P <0.05). 91.11% of the children in the observation group and 86.67% of the family members were significantly higher than the 77.78% in the conventional group and 73.33 in the observation group % Of satisfaction, the difference was significant (P <0.05). Conclusion Budesonide combined with Pulmonary cough in children with asthma can effectively relieve cough, improve lung function, shorten the treatment time, improve children’s therapeutic effect and satisfaction with family members, and help maintain the relationship between doctors and patients and have good clinical application value.